News

MedPage Today on MSN3d
Switch to Dry-Powder Inhaler Worsened COPD, Asthma Patient Outcomes
Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in ...
WebMD22d
COPD Medications: Types, Uses, and Side Effects - WebMD
Learn about COPD medications, including bronchodilators, steroids, and combination treatments. Understand how they work, their side effects, and ways to manage COPD effectively.
Fierce Pharma2d
Respiratory pharma royalty rally around rural COPD education and support drive
Sanofi and Regeneron, AstraZeneca, Roche’s Genentech and GSK have provided support for the Living Well with COPD educational ...
Physician's Weekly8d
Q&A: Can Digital Inhalers Predict Exacerbations of COPD?
Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...
pharmaphorum2d
Asthma and COPD patient adherence: the right inhaler
Large numbers of hospital admissions, along with poor adherence and the prescribing of inappropriate inhalers mean that asthma and chronic obstructive pulmonary disease (COPD) are a huge burden on ...
Fierce Pharma2d
Merck boosts respiratory portfolio with $10B acquisition of Verona and potential COPD blockbuster Ohtuvayre
Merck has pulled off another acquisition which fits in its “sweet spot,” as described by CEO Rob Davis, paying $10 billion ...
Verona Pharma Stock Soars to All-Time High as Merck Buys Firm for $10B
Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.
Healio10d
Q&A: Mepolizumab marks second biologic approved for COPD with eosinophilic phenotype
The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...
The Munich Eye2d
Challenges in Transitioning to Powder Inhalers
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.